While the results involved only two people, there’s still reason for excitement in last week’s report – published in the online journal The Lancet – that two women experienced improved vision after embryonic stem cell therapy.
Said Dr. Steven Schwartz, a retina special at the University of California who treated both patients, “It’s a big step forward for regenerative medicine.” The apparent success carries implications for the use of stem cells to treat other diseases, like Parkinson’s.
Both patients were legally blind. A woman in her 70s suffered from macular degeneration, a leading cause of vision loss among seniors. The other woman, 51, suffered from Stargardt’s macular dystrophy, which effects younger people.
After the 30-minute procedure, the women reported several improvements, like seeing colors better, and being able to thread a needle again.





